Cost-effectiveness of Treatment Options for Prevention of Rheumatic Heart Disease from Group A Streptococcal Pharyngitis in a Pediatric Population
- 1 September 2002
- journal article
- Published by Elsevier in Preventive Medicine
- Vol. 35 (3) , 250-257
- https://doi.org/10.1006/pmed.2002.1062
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Are Follow-up Throat Cultures Necessary When Rapid Antigen Detection Tests Are Negative for Group A Streptococci?Clinical Pediatrics, 2001
- Potential Mechanisms for Failure to Eradicate Group A Streptococci From the PharynxPediatrics, 1999
- The rising incidence of penicillin treatment failures in Group A streptococcal tonsillopharyngitisThe Pediatric Infectious Disease Journal, 1991
- Comprehensive Review of Morbidity and Mortality Trends for Rheumatic Fever, Streptococcal Disease, and Scarlet Fever: The Decline of Rheumatic FeverClinical Infectious Diseases, 1989
- Comparison of a latex agglutination test and four culture methods for identification of group A streptococci in a pediatric office laboratoryThe Journal of Pediatrics, 1986
- Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A streptococciThe Pediatric Infectious Disease Journal, 1985
- Effect of antibiotic therapy on the clinical course of streptococcal pharyngitisThe Journal of Pediatrics, 1985
- The group A streptococcal upper respiratory tract carrier state: An enigmaThe Journal of Pediatrics, 1980
- Does Antimicrobial Therapy of Streptococcal Pharyngitis or Pyoderma Alter the Risk of Glomerulonephritis?The Journal of Infectious Diseases, 1971
- Penicillin Therapy in Acute Tonsillitis, Phlegmonous Tonsillitis and Ulcerative Tonsillitis1Acta Medica Scandinavica, 1951